BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15388993)

  • 1. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
    Magnaldo T; Sarasin A
    Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation assays adapted for DNA repair-deficient keratinocytes.
    Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
    Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
    Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
    Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.
    Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17759-64. PubMed ID: 15598745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
    Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
    Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis.
    Jung EG
    Bull Cancer; 1978; 65(3):315-21. PubMed ID: 719183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
    Kondo S; Satoh Y; Kuroki T
    Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
    Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
    Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
    Magnaldo T
    Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.